Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gastrointestinal (GI) Malignancies”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Testing effectiveness (Phase 2)Ended earlyNCT03724071
What this trial is testing

Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

Who this might be right for
Colorectal NeoplasmDigestive System Neoplasm
Transgene 51
Large-scale testing (Phase 3)Ended earlyNCT00332280
What this trial is testing

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Who this might be right for
Gastrointestinal CancerProstate CancerGenital Neoplasms, Female
Auron Healthcare GmbH 67
Early research (Phase 1)Ended earlyNCT04989387
What this trial is testing

Study of INCA 0186 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsSquamous Cell Carcinoma of the Head and Neck (SCCHN)Gastrointestinal (GI) Malignancies
Incyte Corporation 57
Testing effectiveness (Phase 2)Ended earlyNCT05221320
What this trial is testing

Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies

Who this might be right for
Tumor, SolidGastrointestinal Cancer
BioMed Valley Discoveries, Inc 47
Testing effectiveness (Phase 2)Looking for participantsNCT03539822
What this trial is testing

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Who this might be right for
Gastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more
Anwaar Saeed 117
Early research (Phase 1)Study completedNCT01434069
What this trial is testing

Phase I Trial of Combination of FOLFIRI and SOM 230

Who this might be right for
Gastrointestinal Tumor
H. Lee Moffitt Cancer Center and Research Institute 16
Testing effectiveness (Phase 2)Study completedNCT02575300
What this trial is testing

Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Who this might be right for
Carcinoid TumorsPancreatic NET
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)UnknownNCT02595320
What this trial is testing

Capecitabine in Metastatic Breast and GI Cancers

Who this might be right for
Breast CancerGastrointestinal Cancer
Qamar Khan 200
Testing effectiveness (Phase 2)Ended earlyNCT03628079
What this trial is testing

A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.

Who this might be right for
Cancer of the Gastrointestinal TractCancer of Unknown Origin
Repos Pharma 11
Early research (Phase 1)Ended earlyNCT03449030
What this trial is testing

TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)

Who this might be right for
Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies
Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT01465802
What this trial is testing

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Pfizer 236
Early research (Phase 1)Study completedNCT01640665
What this trial is testing

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors

Who this might be right for
Metastatic Breast CancerGastrointestinal Tumors
Yale University 24
Not applicableWithdrawnNCT05917990
What this trial is testing

Dyadic Text-Messaging Micro-Intervention

Who this might be right for
Advanced CancerGastrointestinal Cancer
Duke University
Early research (Phase 1)Ended earlyNCT00300027
What this trial is testing

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

Who this might be right for
Gastrointestinal Neoplasms
Bristol-Myers Squibb 50
Early research (Phase 1)Study completedNCT01420874
What this trial is testing

Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)

Who this might be right for
Colorectal CancerCancer of PancreasPancreatic Neoplasm+5 more
Barbara Ann Karmanos Cancer Institute 15
Early research (Phase 1)Looking for participantsNCT06414733
What this trial is testing

HER-2 B Cell Peptide Vaccine

Who this might be right for
Metastatic Breast CancerHER2-positive Breast CancerEGFR Overexpression+2 more
Pravin T.P Kaumaya 42
Testing effectiveness (Phase 2)Study completedNCT03531320
What this trial is testing

Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

Who this might be right for
Gastrointestinal CancerBiliary Tract Cancer
InnoPharmax Inc. 19
Testing effectiveness (Phase 2)Ended earlyNCT02241720
What this trial is testing

Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers

Who this might be right for
Upper GI Cancer
University of Utah 5
Not applicableEnded earlyNCT01374100
What this trial is testing

Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell LungCancer of the Gastrointestinal Tract
McGill University 52
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Next Page